Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
To estimate the rates of percutaneous coronary intervention (PCI) outcomes in patients after drug-eluting stents implantation who take statins.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| 1 | Male or female > 18 year of age with indication to PCI |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| To estimate the rates of percutaneous coronary intervention (PCI) outcomes in patients after drug-eluting stents implantation who take statins. | 3 visits for 12 month (before and after PCI) |
| Measure | Description | Time Frame |
|---|---|---|
| To evaluate prognostic factors (demographic, co-morbidity, smoking, LDL-C, inflammatory and cardiac markers) in patients undergoing PCI with drug eluting stent (DES) implantation who take statins and their association with PCI (MACCE) outcomes | 3 visits for 12 month | |
| To estimate Low Density Lipoprotein Cholesterol (LDL-C) target level achievement and lipid-lowering therapy details in patients taking standard lipid lowering therapy prior the PCI. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Hospital patient
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Yuri A Karpov | RCRC (РКНПК) | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Research Site | Moscow | Russia |
Not provided
Not provided
Not provided
Not provided
| 3 visits for 12 months |
| To estimate inflammatory markers (C-reactive protein (CRP) and Leukocytes) in patients prior and after PCI. | 3 visits for 12 months |
| To estimate cardiac markers (Troponin I, brain natriuretic peptide (BNP)) in patients before PCI. | 3 visits for 12 months |
| To study lipoprotein associated phospholipase A2 (Lp PLA2) in patients before PCI and its' association with PCI outcome. | 3 visits for 12 months |
| To study the rate of early and late stent thrombosis according to ARC classification | 3 visits for 12 months |
| ID | Term |
|---|---|
| D050171 | Dyslipidemias |
| D003327 | Coronary Disease |
| ID | Term |
|---|---|
| D052439 | Lipid Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
| D017202 | Myocardial Ischemia |
| D006331 | Heart Diseases |
| D002318 | Cardiovascular Diseases |
| D014652 | Vascular Diseases |
Not provided
Not provided